Estimated Population Prevalence of Heart Failure with Reduced Ejection Fraction in Spain, According to DAPA-HF Study Criteria

Heart failure (HF) is one of the main causes of morbidity, mortality, and high healthcare costs. Dapagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, reduced cardiovascular mortality and hospitalization for HF compared to placebo in patients with chronic HF, and reduced ejection fracti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Med
Main Authors: Camps-Vilaró, Anna, Delgado-Jiménez, Juan F., Farré, Núria, Tizón-Marcos, Helena, Álvarez-García, Jesús, Cinca, Juan, Dégano, Irene R., Marrugat, Jaume
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7408645/
https://ncbi.nlm.nih.gov/pubmed/32635219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9072089
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados